Possible distinct pathogenesis in low responder myasthenia gravis: association of soluble interleukin-2 receptor with acetylcholine receptor antibody titre or abnormal thymus.
AUTOR(ES)
Hayashi, M
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1074004Documentos Relacionados
- Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications.
- Immunological relationship between acetylcholine receptor and thymus: a possible significance in myasthenia gravis.
- Studies of human myasthenia gravis: Electrophysiological and ultrastructural evidence compatible with antibody attachment to acetylcholine receptor complex
- Studies of human myasthenia gravis: electrophysiological and ultrastructural evidence compatible with antibody attachment to acetylcholine receptor complex.
- Anti-acetylcholine receptor antibody measurement in myasthenia gravis.